ClinicalTrials.gg

Program

luvesilocin

Its studies are mostly in Adjustment Disorders · Generalized Anxiety Disorder · Depression, Postpartum · Breast Feeding, led by Reunion Neuroscience.

Furthest: phase 2, since Mar 26, 20244 company-led studies, 2 open or runningNext primary completion: Apr 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Reunion Neuroscience42 open or runningphase 2since Mar 26, 2024Mar 26, 2024Apr 2027phase 2 · NCT07002034

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 26, 2024First study: phase 2 study in Depression, PostpartumFirst studyNCT06342310 · 84 enrolled · United States
  2. Oct 14, 2024Phase 1 study in Breast FeedingNCT06659263 · 14 enrolled · United States
  3. May 23, 2025Phase 2 study in Adjustment DisordersNCT07002034 · 100 planned · United States
  4. Mar 18, 2026Phase 2 study in Generalized Anxiety DisorderNCT07489651 · 160 planned · United States

Ahead

  1. Apr 2027Primary completion: phase 2 study in Adjustment DisordersNCT07002034
  2. Jul 2027Primary completion: phase 2 study in Generalized Anxiety DisorderNCT07489651

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07489651Generalized Anxiety Disorder · United States2RecruitingJul 2027160
NCT07002034Adjustment Disorders · United States2RecruitingApr 2027100
NCT06659263Breast Feeding · United States1CompletedMay 28, 202514
NCT06342310Depression, Postpartum · United States2CompletedMay 22, 202584

How it is read

Names in the registry

  • “RE104 for Injection”, 4 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.